概括
高性欲是帕金森病 (PD) 治疗的副作用,影响3-8%的患者,特别是年轻男性. 治疗包括调整多巴胺替代疗法以改善生活质量.
科学领域:
- 神经学 神经学
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 帕金森病 (PD) 患者经常发展出高性欲,这是冲动控制障碍 (ICD) 的症状.
- 高性欲显著影响患者的生活质量,并影响配偶和照顾者.
- 这种情况与用于PD管理的多巴胺替代疗法有关.
研究的目的:
- 总结帕金森病患者高性欲的发生,危险因素和管理.
- 为了突出多巴胺替代疗法和高性欲之间的关联.
- 为了解决这一具有挑战性的副作用的治疗策略.
主要方法:
- 文献综述和现有关于帕金森病高性欲研究的综合研究.
- 分析流行率,相关风险因素和涉及的药物.
- 对多巴胺诱导高性欲的当前治疗方法的检查.
主要成果:
- 高性欲影响3-8%的帕金森病患者,主要是年轻男性.
- 风险因素包括认知障碍,抑郁病史,病态博和人格特征.
- 多巴胺激动剂比利沃多巴更频繁地与高性欲相关,平均使用药物的持续时间为6.5年.
结论:
- 高性欲是帕金森病的重大负担,需要谨慎的药物管理.
- 调整或停止多巴胺替代疗法,特别是多巴胺激动剂,是主要的治疗策略.
- 对于高风险患者,特别是年轻男性来说,精心选择药物至关重要,以减轻高性欲的发展.
相关概念视频
Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...


